Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
The American Journal of Case Reports|May 8, 2018
Primary Papillary Serous Carcinoma of the Fallopian Tube Presenting as a Vaginal Mass: A Case Report and Review of the LiteratureEinav Kadour-Peero, Lena Sagi-Dain, Gil Cohen, et al.
Oncology|June 9, 2022
Crizotinib in MET Exon 14-Mutated or MET-Amplified in Advanced Disease Non-Small Cell Lung Cancer: A Retrospective, Single Institution ExperienceWalid Shalata, Alexander Yakobson, Sarah Weissmann, et al.
Diagnostics (Basel, Switzerland)|January 8, 2025
Clinical Versus Pathological Staging in Patients with Resected Ground Glass Pulmonary LesionsDan Levy Faber, Abed Agbarya, Andrew Lee, et al.
Translational Oncology|March 15, 2024
Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cellsYifat Koren Carmi, Abed Agbarya, Hazem Khamaisi, et al.
Medical Sciences (Basel, Switzerland)|August 22, 2025
Current and Emerging Therapeutic Strategies for Limited- and Extensive-Stage Small-Cell Lung CancerWalid Shalata, Rashad Naamneh, Wenad Najjar, et al.
Diseases (Basel, Switzerland)|May 24, 2024
A Single-Center Experience in Combined Oncological-Surgical Treatment for Resectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC)Dan Levy Faber, Abed Agbarya, Ben Caspy, et al.
Journal of Clinical Medicine|November 27, 2025
Malignancy in Ground-Glass Opacity Using Multivariate Regression and Deep Learning Models: A Proof-of-Concept StudyAbed Agbarya, Edmond Sabo, Mohammad Sheikh-Ahmad, et al.
Medical Sciences (Basel, Switzerland)|May 27, 2026
Impact of Variant Allele Frequency (VAF) Levels on Clinical Efficacy of Osimertinib in Patients with Metastatic NSCLCAbed Agbarya, Kamel Mhameed, Arina Soklakova, et al.
Biomedicines|March 28, 2024
Prospective Observational Study of COVID-19 Vaccination in Patients with Thoracic Malignancies: Adverse Events, Breakthrough Infections and Survival OutcomesUrska Janzic, Andrej Janzic, Abed Agbarya, et al.
Biomedicines|September 28, 2023
Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung CancerWalid Shalata, Alexander Yakobson, Yulia Dudnik, et al.
Pageof 9